Imovax Rabies Kit
Product Images NDC 49281-252

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Imovax Rabies (NDC 49281-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Imovax 01)

The text appears to describe components of a syringe, including a syringe cap, plunger, syringe tip cap, rod, and barrel. These components are crucial for the function of a syringe in administering medications or fluids.*

FDA Label Image

Figure (Imovax 02)

FDA Label Image

Figure (Imovax 03)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

This is a label of a medical product produced and distributed by Sanofi Pasteur. It contains a unique identification number and contact information for the manufacturer and distributor.*

FDA Label Image

Principal Display Panel (1 mL Syringe Label)

This text is a description of a product called "Sterile Water", which is a diluent used for reconstitution of a substance known as USP R. The product is manufactured by Sanofi Pasteur and does not contain any preservatives. The product has a National Drug Code (NDC) of 49281-263-58 and is identified by the number 768915.*

FDA Label Image

Principal Display Panel (Kit Carton)

This appears to be information about a rabies vaccine called IMOVAX® RABIES. It is a single-dose, lyophilized vaccine that is reconstituted with sterile water and administered through intramuscular injection. It is not for intradermal use. The vaccine is manufactured by Sanofi Pasteur SA in Lyon, France, and distributed by Sanofi Pasteur Inc. in Swiftwater, PA, USA. The vaccine is stored at 2°C to 8°C (35°F to 46°F) and has a potency of equal to or greater than 2.5 IU/mL of rabies antigen.*

FDA Label Image

Principal Display Panel (1 mL Vial Label)

IMOVAX RABIES is a vaccine manufactured by Sanofi Pasteur SA in Lyon, France. The vaccine contains 5% Rabies and is intended for intramuscular injections only. US Government Lic #1724. The vaccine is distributed by Sanofi Pasteur Inc. in Swiftwater, PA, and their contact number is 1-800-VACCINE (1-800-822-2463).*

FDA Label Image

Principal Display Panel (1 mL Syringe Label)

This is a description of a product that has the National Drug Code (NDC) number 49281-249-01. It is a sterile water diluent used for reconstitution of something, possibly a medication or vaccine. The product is manufactured by Sanofi Pasteur and it does not contain any preservatives. The text is accompanied by a barcode labeled "967980".*

FDA Label Image

Principal Display Panel (Kit Carton)

IMOVAX RABIES is a rabies vaccine for human use that is manufactured by Sanofi Pasteur SA in Lyon, France. The vaccine comes in a dose of 1 ml and is distributed by Sanofi Pasteur Inc. The potency of the vaccine is equal to or greater than 2.5 IUmL of rabies antigen, it contains no preservative, and less than 150 ig neomycin sulfate per dose. The vaccine is not for intradermal use, for intramuscular injection only, and is grown in human diploid cell cultures. Storage is recommended at 2°C to 8°C (35°F to 46°F). The package comes with enclosed instructions. CPT Code: 90675.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.